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Abstract
Background:  Bloom syndrome is a rare cancer-prone disorder in which the cells of affected
persons have a high frequency of somatic mutation and genomic instability. Bloom syndrome cells
have a distinctive high frequency of sister chromatid exchange and quadriradial formation. BLM, the
protein altered in BS, is a member of the RecQ DNA helicase family, whose members share an
average of 40% identity in the helicase domain and have divergent N-terminal and C-terminal
flanking regions of variable lengths. The BLM DNA helicase has been shown to localize to the ND10
(nuclear domain 10) or PML (promyelocytic leukemia) nuclear bodies, where it associates with
TOPIIIα , and to the nucleolus.
Results:  This report demonstrates that the N-terminal domain of BLM is responsible for
localization of the protein to the nuclear bodies, while the C-terminal domain directs the protein
to the nucleolus. Deletions of the N-terminal domain of BLM have little effect on sister chromatid
exchange frequency and chromosome stability as compared to helicase and C-terminal mutations
which can increase SCE frequency and chromosome abnormalities.
Conclusion:  The helicase activity and the C-terminal domain of BLM are critical for maintaining
genomic stability as measured by the sister chromatid exchange assay. The localization of BLM into
the nucleolus by the C-terminal domain appears to be more important to genomic stability than
localization in the nuclear bodies.
Background
BLM is a member of the RecQ family of DNA helicases
Bloom syndrome (BS) is a rare cancer-prone autosomal
recessive disorder characterized by genomic instability,
immunodeficiency, infertility and small stature [1,2]. BS
cells have a distinctive genomic instability: a high fre-
quency of sister chromatid exchange (SCEs) and quadr-
iradial formation. BLM, the gene mutated in BS, encodes
a DNA helicase (BLM) of the RecQ family [3]. BLM
shares the most identity in the helicase domain to the
mouse and Xenopus orthologs [4,5,6], to a predicted C.
elegans protein CAB05609 [7], and to D. melanogaster
dmBLM [8]. BLM can partially complement phenotypes
of mutations in the S. cerevisiae SGS1 gene [9,10]. There
are two published reports of BLM knock-out mice: one
strategy used a single deletion allele and found that the
homozygous null mutants are embryonic lethals [4]; the
second strategy used two different deletion alleles and
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recovered full sized, fertile compound heterozygote mice
with an elevated incidence of cancer [5]. The second
mouse model was made with ES cells that have a high
frequency of SCEs before injection and recapitulates the
BS phenotypes more accurately.
There are four other human genes in the RecQ family:
RecQL / RecQl, WRN, RecQ4, RecQ5 [11,12]. WRN is the
gene mutated in Werner syndrome, a premature aging
disorder; WS cells also show features of genomic insta-
bility [13]. WRN encodes an exonuclease activity and
shares many similar in vitro helicase activities with BLM
[14,15]. Mutations in the RECQ4 gene have been found in
persons with Rothmund-Thomson syndrome, a rare pre-
mature aging and cancer-prone disorder [16]. Previous
work from this laboratory and others [10,17,18,19] dem-
onstrated the DNA helicase activity of BLM in vitro on a
variety of DNA substrates. Transfection of the normal
BLM cDNA (but not missense alleles lacking helicase ac-
tivity) into BS cells reduces the frequency of SCEs [10],
indicating that the DNA helicase activity of BLM is es-
sential for genomic stability.
BLM is localized in nuclear bodies and the nucleolus
The BLM DNA helicase is found in two distinct nuclear
structures in normal human cells, ND10 or PML nuclear
bodies (NBs) and the nucleolus [20]. The NBs are dy-
namic PML-dependent depots of multiple proteins dis-
rupted upon viral infection and in certain human
malignancies [21,22,23]. BS cells have NBs of normal
morphology [21,22], and cells lacking PML destabilize
the NBs and have a two fold increase in the frequency of
SCEs [22]. NBs have been implicated in the regulation of
apoptosis [21,24,25] although their precise function is
still unknown. BLM expression is cell-cycle regulated,
showing a marked increase in S phase and peaking in G2
[26,27]. The increase in BLM mRNA and protein expres-
sion coincides with its appearance in the nucleolus [20].
This report uses a series of inducible cell lines containing
deletion alleles of BLM to investigate the role of the N-
terminal and C-terminal domains of BLM in nuclear lo-
calization and in the maintenance of genomic stability.
We find that the N-terminal domain directs BLM for
packaging in NBs, while the C-terminal domain is re-
quired for efficient nucleolar localization. Compared to
the normal BLM protein, deletions of the C-terminus and
mutation of the helicase domain have a strong negative
effect on genomic stability whereas deletions of the N-
terminus have less effect.
Results
GFP-BLM has in vitro DNA helicase activity
Epitope-tagged genes facilitate the analysis of transfect-
ed cell lines and protein recovery. The green fluorescent
protein (GFP) is especially useful as a reporter and
epitope tag due to its ease in detection and apparent in-
dependent folding that does not interfere with the activ-
ity of its fusion partner [28]. A GFP-BLM expressing
recombinant baculovirus was produced in Sf9 cells. Sin-
gle virus isolates expressing GFP-BLM were identified
using FACS and PCR analysis [29]. Sf9 cells infected with
the purified primary stocks were screened by immun-
ofluorescent microscopy to verify accumulation of GFP-
BLM in the nucleus (Figure 1A). This screening verified
full length expression as GFP is fused to the N-terminus
of BLM and the nuclear localization signal is in the last
100 amino acids of the 1417 amino acid BLM coding re-
gion [30]. GFP-BLM accumulates in the nucleus of in-
fected Sf9 cells as large aggregates (Figure 1A). This
observation is consistent with a report of BLM oligomer-
ization [31]. This property is an obstacle to purification
as only about 10% of the expressed GFP-BLM is soluble.
GFP-BLM was purified using ion-exchange and metal
chelate resin chromatography (Figure 1B). The purified
protein has DNA-dependent ATPase activity and DNA
unwinding activity (Figure 1C & 1D) equivalent to previ-
ous preparations without GFP expressed in S. cerevisiae
cells [10]. GFP-BLM has 5 units/ng unwinding activity
and 10 units/ng DNA-dependent ATPase activity as
compared to 6 units/ng and 7 units/ng for BLM purified
from yeast. These data demonstrate that GFP-BLM has
the same enzymatic activity as normal BLM and GFP-
tagged variant alleles can be used to discover the func-
tional domains of BLM.
Selection and analysis of transfected cell lines expressing 
normal and mutant BLM alleles under doxycycline control
An SV40-transformed BS cell line (GM0855B) was
transfected with a plasmid containing an expression unit
for the tetracycline or doxycycline (Tet) responsive tran-
scriptional transactivator [32]. Only one cell line
(HG2522.1a) out of 17 showed good responsiveness (15
fold) and low uninduced background expression levels
(0.25% green cells). A series of deletion alleles of the nor-
mal BLM cDNA (B3) [3] were constructed using restric-
tion sites and oligonucleotide adapters (Figure 2). These
genes were made as in frame fusion genes at the C-termi-
nus of EGFP and cloned behind the Tet-responsive pro-
moter in plasmid pTRE. HG25221a cells were
transfected with the normal and mutant GFP-BLM genes
and stable hygromycin-resistant cell lines were selected.
Clones were picked and screened for nuclear localized
green fluorescence after induction. Cell lines expressing
each construction were chosen for further study when
the background level of green cells was less than 10% and
the percentage of green cells after induction was repro-
ducibly elevated (Table 1).BMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
Figure 1
Purification and Assay of GFP-BLM. A. Fluorescent microscope image of GFP-BLM in the DAPI-stained nucleus of an Sf9
cell 72 hours after infection with a recombinant baculovirus. GFP-BLM forms large green aggregates. B. Silver-stained SDS 4-
12% polyacrylamide gel of the purification of GFP-BLM using Macroprep Q ion exchange chromatography followed by metal
chelate resin chromatography. Lane Q shows the ion exchange column pool of the green GFP-BLM fractions and lanes W1-
W3 are proteins eluted from the metal resin with increasing imidazole washes (wash1 = 10 mM, wash2 = 50 mM, wash3 = 100
mM). The elution lanes show purified GFP-BLM eluted with a final step of 200 mM imidazole. The molecular weights (MW) of
the standard markers (BioRad Precision) are indicated. C. Autoradiogram of a thin-layer plate ATPase assay of GFP-BLM. The
amount of protein in the assay is shown. The addition of single-stranded Mpl8 DNA is indicated. Calf intestinal phosphatase
(CIP) is used as a positive control for [γ -32P]ATP hydrolysis. D. Unwinding of a 32P-labeled 54 base oligonucleotide annealed to
Mpl8 DNA by GFP-BLM. The position of the substrate (S) and the product (P) on the autoradiogram of a 10% polyacrylamide
gel are indicated. The gel shows reactions containing 25 ng of GFP-BLM incubated for increasing time at 27°C and unwinding by
increasing amounts of GFP-BLM incubated at 27°C for 30 minutes.BMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
Figure 2
BLM Mutation Map. A diagram of the of the deletion and missense alleles of BLM used in this study. The amino acids
removed by each deletion are: ∆ N1 (2-128), ∆ N2 (135-235), ∆ N3 (241-469), ∆ N4 (402-600), ∆ H1 (903-1115), ∆ C1 (1118-
1164) and ∆ C2 (1166-1331). The location of the missense allele K695T is shown. The red boxes indicate positions of regions
of the N-terminus of BLM that have a high density of aspartic and glutamatic acid residues: region 1 (261-310 = 42% DE) and
region 2 (541-570 = 50% DE). Deletion N3 removes a serine-rich region (310-320 = 64%S). The blue box indicates the location
of the nuclear localization signal [29] (NLS = 1331-1350). The two regions of reported in vitro interaction of BLM with TopIIIα
(143-213 & 1266-1417) are marked [34]. The helicase domain consists of residues 672-985 and the HRD (Helicase and
RNaseD identity domain) [41] is indicated (1212-1293).
Table 1: Phenotypes of transfected cell lines expressing inducible GFP-BLM alleles.
Localization Relative Relative
Cell Line % green cells % green of GFP-BLM Expression Expression
no inducer cells +Tet fusion proteins no inducer +Tet
GFP 8 33 diffuse (NM1) nd nd
GFP-BLM 1 94 NBs + NM2 0.16(0.03) 1.0(0.15)
GFP-∆ N1 1 75 NM2 (3% NBs) 0.17(0.05) 0.96 (0.3)
GFP-∆ N2 9 90 NM2 0.30(0.08) 2.28 (0.35)
GFP-∆ N3 2 74 NM2 + BBs 0.05(0.02) 0.87(0.12)
GFP-∆ N4 1 77 NM1&2 0.09(0.01) 0.81 (0.09)
GFP-K695T 3 30 NBs + NM2 + BBs 0.12(0.01) 0.45 (0.08)
GFP-∆ H1 3 80 NBs +NM3 0.02(0.01) 0.39 (0.08)
GFP-∆ C1 1 77 NBs + BBs 0.04(0) 0.83 (0.03)
GFP-∆ C2 5 82 NBs + BBs 0.01(0) 0.74 (0.06)
At least 200 DAPI-stained cells were counted and scored for green fluorescence to determine the percentages of induced and uninduced cells ex-
pressing the GFP-BLM fusion proteins. All GFP-fusion proteins show diffuse nuclear staining. The nucleolar morphologies (NM) of each fusion protein 
are reported as shown in Figure 4. NM1 is a diffuse overall nucleolar localization (Figure 4A & 4H). NM2 is overall nucleolar fluorescence with ex-
clusion from central holes " TOPIIIα . BBs are numerous spherical BLM-containing nuclear bodies that do not co-localize with either antigen. At least 
300 cells were examined for determination of nuclear morphologies. Expression levels of the fusion proteins without Tet and with 1 µg/ml Tet rel-
ative to normal BLM are reported as determined in Figures 3 & 5. The values reported are the average of two experiments. The standard deviation 
for these data points is shown in parentheses beside each value.BMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
GFP-BLM expression can be regulated by inducer concen-
tration
The level of GFP-BLM produced with increasing
amounts of Tet after a 24 hour induction period was de-
termined (Figure 3). The expression of GFP-BLM was
calculated relative to the amount of BLM present in a
normal SV40-transformed fibroblast line (GM0637B).
Tet concentrations from 0.25-2 µg/ml produced levels of
stable GFP-BLM expression in this SV40-transformed
BS cell line similar to the amount found in the control
cell line. Based on these data 1 µg/ml and 24 hours were
used as the standard induction conditions to evaluate lo-
calization and SCE frequency of the transfected cell lines.
Stable cell lines containing the mutant proteins are induc-
ible with Tet and show altered localization
The cell lines chosen for study contain some constitutive
expression of the BLM alleles but show good reproduci-
ble induction (Table 1). The localization of the normal
and mutant GFP-BLM proteins was analyzed by immun-
ofluorescent microscopy (Figure 4). Antibodies against
PML and topoisomerase IIIα  [33] were used as marker
proteins for the NBs. A human autoimmune serum
against a nucleolar antigen ANA-N was used for nucleo-
lar co-localization (data not shown). The cell line ex-
pressing GFP alone showed diffuse nuclear and
cytoplasmic green fluorescence (Figure 4A). The normal
GFP-BLM fusion protein localizes to NBs and the nucle-
olus (Figure 4B) as previously reported for BLM in nor-
mal human fibroblasts [20]. The fusion protein co-
localizes with PML and TOPIIIα  (Figure 4B & 4C) as
does normal BLM [20,21,22,33,34]. GFP-BLM is distrib-
uted throughout the nucleolus except for several central
regions that appear as holes in the images. The N-termi-
nal deletions of BLM show little NB localization and ∆ N1
through  ∆ N3 retain the nucleolar localization pattern
(Figure 4D,E,F,G). The ∆ N4 fusion protein shows mostly
diffuse localization but nucleolar localization is still evi-
dent (Figure 4H). In 95% or more of the cells in the in-
duced populations there is little co-localization with
PML or TOPIIIα  (Figures 4D,E,F,G, Table 1). These re-
sults demonstrate that the normal GFP-BLM fusion pro-
tein restores the BLM nuclear localization pattern to this
BS cell line and deletions of the N-terminus affect the
packaging of BLM into the NBs.
The N2-N4 regions of BLM are required for NB localiza-
tion
By visual inspection each induced cell line contains cells
expressing different levels of the fusion proteins. The
∆ N1 expressing cells which exhibit the most intense
green fluorescence comprise 3% (10 cells out of 300
counted) of the population and show co-localization of
the GFP signal with α -PML and α -TopIIIa. This small
number of cells is identical to cells expressing normal
GFP-BLM (Figure 4B & 4C). The cell lines expressing
∆ N2, ∆ N3 and ∆ N4 do not show NB localization (0 out of
300 cells). Since the ∆ N1 protein shows partial co-locali-
zation with NBs the N1 region is not absolutely required
for BLM to be localized there. The other N-terminal do-
mains are required for NB localization.
The helicase and C-terminal mutations of BLM have very 
different effects compared to the N-terminal mutations
The two GFP-fusion proteins with mutations in the heli-
case domain have different localization patterns. The
K695T missense protein localizes to NBs, but less effi-
ciently than normal BLM, and to the nucleolus with an
altered morphology (Figure 4I). The K695T fusion pro-
tein is not evenly distributed throughout the outer nucle-
olar region but shows areas of concentration and larger
central holes. The ∆ H1 fusion protein has a diffuse local-
ization pattern throughout the nucleus and has a distinct
altered nucleolar localization (Figure 4J). This fusion
protein appears in the central holes of the nucleolus
where the normal fusion protein is not found. Co-locali-
zation of the H1 fusion protein and α -PML and
TOPHI11α  is seen in most cells, and fewer NBs are
present. The GFP-fusion proteins with helicase muta-
tions are packaged into the NBs and have altered nucle-
olar localization.
The two GFP-fusion proteins with C-terminal mutations
have different localization patterns than the N-terminal
mutations. The ∆ C 1 and ∆ C2 fusion proteins co-localize
efficiently with α -PML and α -TOPIII (Figure 4K & 4L)
and have little nucleolar localization. In addition the C-
terminal deletion proteins form numerous small green
nuclear bodies that do not co-localize with either NB an-
tibody (BLM bodies, BBs). These BBs are found in cells
expressing the ∆ N3 and the K695T proteins (Figure 4H
& 4I). The BBs may be due to formation of large oligom-
ers or aggregates of less soluble fusion proteins. The sig-
nificance of these aggregates is unknown. These
observations demonstrate that the N-terminal domain of
BLM is required for NB localization and the C-terminal
domain is required for accumulation of BLM in the nu-
cleolus.
The mutant fusion proteins are made as stable full-length 
proteins
The differences in localization pattern between the nor-
mal and mutant alleles of BLM is not due to vastly differ-
ent levels of stable fusion protein expression. Western
analysis showed that all of the GFP fusion genes are in-
ducible and are made as full-length proteins (Figure 5).
The N-terminal deletion fusion proteins do not fail to go
to NBs because of reduced fusion protein expression in
these cell lines. They are expressed as stable full length
fusion proteins at levels close to those of the normalBMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
Figure 3
The expression of GFP-BLM is inducible in stable transfected BS cells. A. Equal amounts of total protein (10 µg)
from whole cell lysates were resolved on a SDS-polyacrylamide gel and transferred to a membrane. The bound primary α -BLM
and goat α -rabbit alkaline phosphatase conjugated secondary antibody complexes were quantitated using a ECF fluorescent
alkaline phosphatase substrate. 1) GM0637G normal SV40-transformed fibroblast cells (0.17), 2) HG2522-1a cells + GFP-BLM
gene no inducer (0.03), 3) +0.0625 µg/ml Tet (0.05), 4) +0.125 µg/ml Tet (0.11), 5) +0.25 µg/ml Tet (0.16), 6) +0.5 µg/ml Tet
(0.3), 7) +1 µg/ml Tet (0.3), 8) +2 µg/ml Tet (0.14). The ECF fluorescent product was visualized directly with a Molecular
Dynamics Storm PhosphorImager. B. The fluorescent image was quantitated using Imagequant. The amount of BLM in the
lysates was normalized to the amount in equivalent total protein in the GM0637G cells. The data points are the average of two
experiments. The standard deviations for each concentration are reported in parentheses above.BMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
Figure 4
Localization of GFP-BLM fusion proteins. The immunofluorescent images show representative cells from each trans-
fected cell line. Localization of GFP or GFP-BLM fusion proteins and PML (α -PML and Donkey α -mouse Texas Red secondary)
or TOPIIIα  (α -TOPIIIα  and Donkey α -rabbit Texas Red secondary) in DAPI-stained nuclei are shown. A. EGFP + α -PML. B.
GFP-BLM + α -PML. C. GFP-BLM + α -TOPIII. D. GFP-∆ N1 + α -PML. E. GFP-∆ N2 + α -PML. F. GFP-∆ N2 + α -TOPIII. G. GFP-
∆ N3 + α -PML. H. GFP-∆ N4 + α -PML. L GFP-K695T + α -PML. J.GFP-∆ H1 + α -PML K. GFP-∆ C1 + α -PML. L. GFP-∆ C2 + α -
TOPIII. The parental SV40-transformed BS cell line lacks detectable BLM [10].BMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
Figure 5
Western analysis of stable transfected cell lines expressing mutant BLM alleles. A. Whole cell lysates (15 µg total
protein) from uninduced and induced cells were resolved on 4-12% SDS polyacrylamide gels and transferred to PVDF mem-
branes. The bound complexes were detected with ECL reagents and exposed to x-ray film: 1) GFP-BLM+Tet, 2) GFP-∆ N1 no
Tet, 3) GFP-∆ N1+Tet, 4) GFP-∆ N2 no Tet, 5) GFP-∆ N2+Tet. 6) GFP-∆ N3 no Tet, 7) GFP-∆ N3+Tet, 8) GFP-∆ N4 no Tet, 9)
GFP-∆ N4+Tet. B. ECL western analysis of whole cell lysates: 1) GFP-BLM+Tet, 2) GFP-K695T no Tet, 3) GFP-K695T+Tet, 4)
GFP-∆ H1 no Tet, 5) GFP-∆ H1+Tet, 6) GFP-∆ C1 no Tet, 7) GFP-∆ C1+Tet, 8) GFP-∆ C2 no Tet, 9) GFP-∆ C2+Tet. The posi-
tions of molecular weight standards are indicated to the left. Filters were reacted with α -GFP and goat α -mouse secondary
conjugated with horseradish peroxidase. The bound complexes were detected with ECL reagents and exposure to x-ray film.
C. Identical filters were reacted with α -GFP and goat α -mouse secondary conjugated with alkaline phosphatase. The fluores-
cent ECF product was visualized with a Molecular Dynamics Storm. The fluorescent image was quantitated using Imagequant.
The values were normalized to normal GFP-BLM expression.BMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
GFP-BLM fusion protein (Table 1, Figure 5). The ∆ N2
protein is relatively over-expressed under the induction
conditions used, while the ∆ N3 and ∆ N4 proteins are ex-
pressed at near normal levels under the same induction
conditions. The N-terminal deletion alleles have higher
levels of constitutive expression relative to the C-termi-
nal mutations and have overall higher levels of protein
expression; one explanation is that the C-terminal muta-
tions are deleterious.
Most N-terminal mutations have little effect on genomic 
stability as measured by SCE frequency
BS cells have an elevated frequency of SCEs [1]. This in-
crease in homologous recombination leads to an in-
creased somatic mutation frequency and genomic
instability. The SCE frequency was assayed in the induc-
ible cell lines (Figure 6, Tables 2 & 3). The cell line ex-
pressing GFP alone had a nearly identical frequency of
SCEs with and without induction (65 vs. 70 exchanges
per 46 chromosomes). The GFP-BLM cell line had an el-
evated baseline level (40 exchanges) but showed signifi-
cant reduction upon addition of inducer (40 to 12
exchanges). The ∆ N1, ∆ N2 and ∆ N3 cell lines showed less
reduction (17-23 exchanges) and slightly higher baseline
levels (47-58 exchanges). These cell lines also have a dis-
tribution of SCEs slightly elevated relative to normal (Ta-
ble 2, Figure 6A). The ∆ N4 cell line has a different
distribution and shows less correction of the SCE fre-
quency (Table 2, Figure 6A). The N-terminal deletion
proteins show a gradual increase in the range of the SCEs
as the deletions approach the helicase domain (Table 2).
The helicase and C-terminal mutations have a destabiliz-
ing effect
The helicase and C-terminal mutations have a greater ef-
fect on genomic stability than do the N-terminal muta-
tions (Table 2 & 3, Figure 6A). There is a polarity of loss
of function seen across the gene from the N-terminus to
the C-terminus (Figure 6A & 6B). Most of the C-terminal
mutations appear to have a dominant negative effect, as
the frequency of SCEs is higher with Tet than without.
The most dramatic effects are seen in the ∆ C1 and to a
lesser degree in the ∆ C2 induced cultures, as evidenced
by an elevated frequency of ring chromosomes [35] (Ta-
ble 3, Figure 6C). This may indicate breakage and rejoin-
ing events or tangled telomeres. The cell line containing
the helicase deletion, ∆ H1, has an elevated basal frequen-
cy of SCEs and a higher chromosome number than the
GFP control cell line (Table 3) yet does not appear to be
as deleterious as the K695T and C-terminal deletions are
when comparing relative SCE events. The SCE analysis
of this cell line was complicated by difficulty in finding
chromosome spreads and by the small number of met-
aphases present in the cultures. Many of the metaphases
could not be counted, as the chromosomes did not sepa-
rate under the optimized spreading conditions that
worked efficiently for the other cell lines. The SCE assay
is therefore biased towards resolved or more corrected
metaphases and it is likely that the induced ∆ H1 SCE fre-
quency is actually higher than reported here. The SCE as-
say was successful for all cell lines indicating that the
doubling times are close to 24 hours. This indicates that
the overall cell cycle timing is similar in all of the cell
lines but does not rule out variations in stage-specific
progression.
Table 2: Sister Chromatid Assay of Transfected Cell Lines: exchange data
Mean # of Mean # of
Cell Line SCEs per SCEs per Range of Range of % Relative
46Cs-Tet 46Cs +Tet SCEs -Tet SCEs +Tet Correction
GFP 70 65 58-96 55-75 7
GFP-BLM 40 12 30-49 10-19 70
GFP-∆ N1 56 20 32-73 12-29 64
GFP-∆ N2 47 17 25-63 9-27 64
GFP-∆ N3 58 23 40-85 11-35 60
GFP-∆ N4 66 45 46-89 20-68 30
GFP-K695T 84 106 63-118 79-131 -26
GFP-∆ H1 108 95 84-159 87-142 12
GFP-∆ C1 63 89 42-101 44-205 -41
GFP-∆ C2 68 78 51-82 59-108 -15
Frequency of SCEs are shown as mean number of exchanges per 46 chromosomes (Cs) for at least 20 metaphases for each cell line without inducer 
and with inducer. The range of the SCEs is shown. The relative percentage correction is calculated from the ratio of the mean number of exchanges 
per 46 chromosomes +Tet / the mean number of exchanges per 46 chromosomes - Tet. The cell line expressing GFP alone is 0.93 and 7% correction. 
The GFP-BLM cell line ratio is 0.3 and 70% correction. Cell lines were induced with 1 µg/ml Tet.BMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
Figure 6
SCE Assay on cell lines with and without inducer. A. Histogram of the distribution of SCEs from induced cell lines. The
number of SCEs per 46 chromosomes is plotted vs. the number of cells or metaphases. B. Graphical representation of the rel-
ative correction for each GFP-BLM allele (Table 2 & 3). C. Metaphase chromosome spread from an induced cell transfected
with GFP-∆ C1 BLM. A large ring chromosome is shown at the top of the spread. The SCEs are visualized with acridine orange
staining.BMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
The expression of the C-terminal mutations is deleterious 
relative to the N-terminal mutations
The C-terminal deletion containing cell lines have a high-
er mean chromosome number than the control and N-
terminal deletion cell lines, except for the ∆ N1 cell line
which is somewhat elevated (Table 3). This increase in
chromosome number suggests that the C-terminal muta-
tions lead to an increase in the aneuploidy of these SV40-
transformed cells by inhibiting proper chromosome sep-
aration. The increase in SCE frequency correlates with an
overall lower level of fusion proteins in the C-terminal
mutation cell lines and higher levels of protein expres-
sion in the cell lines with N-terminal deletions. These
data demonstrate that mutation of the helicase and C-
terminal domains of BLM have a greater effect on the
SCE frequency than does mutation of the N-terminal do-
main.
Discussion
The Tet-on system has strengths and weaknesses
The Tet inducible expression system has experimental
weaknesses in that the activity of the Tet-responsive ac-
tivator is not tightly regulated and some cells do not pro-
duce inducible cell lines. All of the GFP-BLM fusion
proteins were produced at a low level in the absence of
inducer. Cell lines with a favored reproductive potential
grew well and multiple useful stable transfectants were
obtained (normal BLM and N-terminal deletion genes)
as compared to those containing deleterious mutant alle-
les (helicase and C-terminal deletions). The BS cell line
used here lacks BLM [10] and all cell lines obtained from
transfection of the normal GFP-BLM gene had a back-
ground level of constitutive expression leading to a par-
tially corrected SCE frequency relative to the parental
line (40 vs. 58) [10]. EGFP itself is not an innocuous pro-
tein. The cell lines expressing EGFP alone grew the most
slowly of all of the clones in the collection and had a
slightly elevated SCE frequency relative to the parental
cell line (65-70 vs. 58 exchanges) [10]. When co-trans-
fections were performed with one plasmid containing the
Tet-responsive GFP-BLM gene and another containing
the selection unit, all of the cell lines tested had low SCEs
without induction (4 of 4). Only when both the GFP-BLM
and hygromycin-resistance expression units were com-
bined on the same plasmid were useful inducible clones
recovered. Despite the time and effort required to screen
multiple clones, some with constitutive levels of expres-
sion, experimentally useful cell lines were obtained that
allowed investigation of the function of the N-terminus
and C-terminus of BLM.
The Tet-inducible system shows better SCE correction 
than constitutive expression
Our previous study used stable transfected cell lines de-
rived from the same SV40-transformed BS cell line used
here, except that the normal and missense alleles of BLM
were expressed from a constitutive promoter [10]. The
normal BLM cDNA reduced the SCE frequency from 58
to 24 exchanges per 46 chromosomes. This is partial cor-
rection as normal cell lines have from 4-10 exchanges per
46 chromosomes [1]. In addition the cells expressing the
helicase-defective K695T allele grew slowly and eventu-
ally died. These results led us to use an inducible expres-
sion system. In this study the SCE frequency of the
induced normal GFP-BLM cell line is closer to correction
(12 exchanges). The K695T protein localizes in a pattern
similar to the normal protein yet increases the SCE fre-
quency, suggesting that the dominant negative effect of
this allele caused the cell lines made in the previous
study to die. Despite the limitations discussed above, the
Tet-on system allowed isolation of inducible cell lines
which more accurately paralleled normal than did lines
Table 3: Sister Chromatid Assay of Transfected Cell Lines: chromosome data
Cell Line Mean # of Mean # of Range of # of Range of # of Ring Cs to Ring Cs to
Cs-Tet Cs+Tet Cs-Tet Cs+Tet Total Cs -Tet Total Cs +Tet
GFP 57 58 40-112 48-69 0/1116 0/1140
GFP-BLM 67 67 60-75 61-70 0/1340 0/1340
GFP-∆ N1 78 74 61-103 58-112 0/1560 0/1480
GFP-∆ N2 58 63 50-70 58-67 0/1116 0/1260
GFP-∆ N3 62 60 48-72 56-68 0/1240 0/1200
GFP-∆ N4 55 57 48-71 50-103 0/1100 0/1114
GFP-K695T 60 62 48-68 56-70 0/1200 0/1240
GFP-∆ H1 84 82 52-102 54-102 0/1680 0/1640
GFP-∆ C1 105 95 77-203 88-150 1/2100 7/1900
GFP-∆ C2 88 88 58-102 76-100 0/1760 3/1760
The mean number of chromosomes (Cs) per metaphase is shown for each cell line. The range of the chromosome number is shown. The number 
of ring chromosomes found is reported as number per total chromosomes examined for each cell line. Cell lines were induced with 1 µg/ml Tet.BMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
with a constitutive promoter, and allowed the isolation
and evaluation of cell lines expressing deleterious alleles.
The NBs appear to be regulatory depots for BLM
All of the N-terminal deletion proteins are expressed at a
stable level near normal, reduce the SCE frequency to
near normal, and are not efficiently packed in the NBs.
Cells which lack PML do not form NBs and have approx-
imately a two-fold increase in SCE frequency relative to
control cells [29]. This is similar to the SCE data for the
N-terminal BLM deletions and demonstrate that NB lo-
calization is not a requirement for BLM function. NBs
are likely to be storage locations or depots that regulate
the release or recovery of BLM. All of the N-terminal de-
letion proteins except for ∆ N4 show nucleolar morphol-
ogies and SCE frequencies close to normal. The ∆ N4
protein has a lower correction efficiency and a different
localization pattern than the other N-terminal deletions.
This deletion removes a cluster of acidic amino acids,
similar to acidic activation domains known to activate
transcription in a variety of eucaryotes [36]. Clusters of
acidic amino acids that function as transcriptional acti-
vation domains can also activate chromosomal DNA rep-
lication by interacting with replication protein A (RPA)
[37]. BLM interacts with RPA70 in vitro [38] and associ-
ates with RPA clusters in cells [20]. Other studies have
demonstrated that acidic activators can relieve nucleo-
somal repression and that the anti-repression function
may be mediated by chromatin remodeling systems [39].
Deletion of this acidic cluster of BLM has an effect on lo-
calization and SCE frequency and may target BLM to
RPA bound to single-stranded DNA, or it may allow BLM
to function with chromatin remodeling complexes at
sites of ectopic invasion events.
The N-terminal deletions do not efficiently associate
with TOPIIIα  by immunofluorescent examination. This
does not rule out binding with TOPIIIα  in the more dif-
fusely stained regions. Studies in S. cerevisiae suggest
that BLM and TOPIIIα  function together as an enzymat-
ic complex [33, 34]. Alternatively TOPIIIα  could regulate
BLM activity by altering its ability to bind DNA sub-
strates. In vitro binding studies [34] identified two re-
gions of BLM (amino acids 143-213 & 1266-1417, Figure
2) that interact with TOPIIIα . One of these regions (143-
213) is removed by the ∆ N2 construction. The cells ex-
press TOPIIIα  in multiple sized spherical bodies but no
co-localization with the GFP fusion protein is evident
(Figure 4F). It is possible that TOPIIIα  binds BLM only
when BLM is in NBs or that the C-terminal BLM binding
domain is of low affinity.
The nucleolus is likely to be an important site for BLM 
function
The C-terminal deletion proteins do co-localize with
PML and TOPIIIα  in the NBs yet elevate the SCE fre-
quency. The helicase and C-terminal mutations that fail
to localize normally in the nucleolus fail to reduce the
SCEs and implicate the nucleolus as a functional location
for BLM during DNA replication. One study on chromo-
some abnormalities in cells from persons with BS docu-
mented an elevated frequency of recombination events
in the satellite stalks of acrocentric chromosomes [40].
In this report lymphocyte chromosomes from two per-
sons with BS were compared to those from unaffected
persons. The frequency of exchanges in the BS cells was
estimated to be 6/1000 and less than 0.1/1000 in control
cells. In addition the cells from one of the persons with
BS had acrocentrics with Q-bright satellites. The lym-
phocytes from this individual varied greatly with regard
to the number of Q-bright satellites and which acrocen-
tric chromosomes contained them, documenting a high
frequency of recombination in the rDNA loci of BS cells.
These data are consistent with a model in which BLM
functions to untangle invasive events in multiple rDNA
loci and SCEs are used as a bypass mechanism when
BLM is absent.
The localization of BLM in the nucleolus is not an artifact 
but rather a function specified by the C-terminal domain
The precise function of the C-terminus that directs BLM
to the nucleolus is still unclear. An NMR structural anal-
ysis of the HRD domain of Sgs1p and models for the
WRN and BLM domains suggests that this region is a
single-strand nucleic acid binding domain that functions
as an accessory DNA binding region with the helicase do-
main [41]. Helicase motifs are conserved in many pro-
teins. The specific function of individual helicases may
be controlled by a substrate selection mechanism in the
accessory regions flanking the helicase domain. The C-
terminus may confer on BLM the ability to recognize and
bind abnormal DNA structures such as quadraplexes
[17]. Alternatively the flanking regions may bind to re-
combination proteins such as RPA or RAD51 at these
chromosomal sites [38]. The dominant negative nature
of the C-terminal deletions suggests that these mutant
proteins can be incorporated into normal BLM-contain-
ing complexes and inhibit function or regulation. The
numerous BLM bodies formed by the C-terminal dele-
tion fusion proteins may sequester repair complexes that
BLM has been shown to associate with [42].
Many of the cell lines showed modest levels of over-ex-
pression of the fusion proteins relative to levels of BLM
found in a normal SV40-transformed cell line. The im-
munofluorescent images show an apparent greater accu-
mulation of fusion protein in the nucleolus than is foundBMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
in normal cells [20]. The stronger signals are caused by
the expression levels as well as the sensitivity of the GFP
reporter gene. When proteins are over-expressed they
can localize non-specifically. The advantage of the sys-
tem here is that the parental cell line lacks BLM and
therefore the fusion protein can occupy normal positions
without competing with endogenous BLM. The GFP-
BLM fusion protein accumulates in the same nuclear
structures as determined previously [20] and does not
appear to cause aberrant structures at the levels ex-
pressed here.
BLM most likely functions in recombinational repair dur-
ing DNA replication
The DNA helicases of the RecQ family are not essential
for cellular viability but are important to genomic stabil-
ity. Studies in model organisms suggest a role for the hu-
man orthologs in recombinational repair during DNA
replication. Experimental evidence shows that RecQ and
nuclease RecJ act together to restart stalled forks in E.
coli [43]. A recent study of the S. cerevisiae Sgs1p gene
suggests that it removes or prevents ectopic recombina-
tion events between non-homologous chromosomes
[44]. Experiments with X. laevis BLM demonstrates its
requirement in a reconstituted DNA replication system
[6]. The in vitro enzymatic activities documented for
BLM, unwinding G4 quadraplexes, holliday junctions
and D-loops [17,18,19], as well as the phenotypes of BS
cells [1] are consistent with both of these models. BLM
has been localized to two GC-rich repeated regions (nu-
cleolus and telomeres) [20] where the replication ma-
chinery is likely to need assistance to back up in order to
untangle stalled forks and resolve inappropriate invasive
events between repeated sequence elements found on
multiple chromosomes. BLM has been found in large
protein complex with BRCA1 and multiple DNA repair
and replication factors [42] that may recognize and re-
pair abnormal DNA structures that occur during DNA
replication. As both the helicase activity and the C-termi-
nus of BLM are required to maintain genomic stability it
is likely that the C-terminus of BLM recognizes abnormal
DNA structures and the helicase activity unwinds these
multi-stranded structures to engender efficient repair.
Conclusions
The GFP-BLM fusion protein has helicase activity in vit-
ro and functions to reduce the SCE frequency in BS cells.
Deletions of BLM expressed as GFP fusion proteins dem-
onstrate that the N-terminal domain directs BLM into
nuclear bodies and the C-terminal domain is necessary
for efficient nucleolar localization. The stable nucleolar
localization of BLM is not due to over-expression but
rather to a function encoded in the C-terminus of BLM.
Mutations in the helicase domain and deletions in the C-
terminal domain have a dominant negative effect on the
SCE frequency and cause an increase in chromosome ab-
normalities, whereas N-terminal deletions have relative-
ly little effect. These data demonstrate that the helicase
activity and C-terminal domain directed nucleolar local-
ization of BLM is essential to maintain genomic stability.
The NBs appear to be storage or regulatory sites for BLM
and are not required for BLM activity.
Materials and Methods
Expression and purification of GFP-BLM
The normal BLM cDNA (B3) [3] was fused to the C ter-
minus of EGFP (Clontech). An 8x polyhistidine epitope
tag was added to the N-terminus of EGFP with an oligo-
nucleotide adapter (5'AAAACTGCAGCGGCCGCCAC-
CATGCACCAC-
CACCACACCACCACCACGTGAGCAAGGGCGAGGAGC
TGTTCACCG3'). DNA sequencing confirmed the con-
struction. A recombinant baculovirus expressing the fu-
sion gene behind the polyhedrin promoter was made in
Sf9 cells using Invitrogen's BlueBac kit according to the
supplier's protocol. Sf9 cells were infected for 72 hours at
a multiplicity of infection (MOI) of 1 and sorted for green
cells by FACS analysis (MoFlo, Cytomation) at one and
ten cells per well into 96 well microtiter plates containing
uninfected Sf9 cells [29]. These primary viral stocks were
assayed and amplified by infecting Sf9 cells in 24 well
plates. The secondary stocks were analyzed by PCR and
screened for a nuclear-localized GFP signal [30]. Viral
stocks containing only the recombinant GFP-BLM con-
struction were amplified to produce high titer stocks for
expression. Maximal expression of GFP-BLM was found
to be 72 hours of infection by western analysis with α -
BLM [10]. Sf9 cells in Sf900-II medium (Invitrogen)
were infected at a MOI of 5-10 and harvested after 72
hours. Efficiency of infection was monitored by immun-
ofluorescent microscopy (Figure 1A). The cell pellets
were stored at -70°C.
Cell lysis was monitored by fluorescent microscopy and
aliquots of column fractions were assayed in the wells of
96 well microtiter plates for green fluorescence using a
Molecular Dynamics Storm Phosphorlmager. The frozen
cell pellets from 500 ml spinner flask culture were lysed
by sonication in Buffer A (50 mM Tris-HCL pH 8, 5 mM
β -mercaptoethanol, 1 mM EDTA, 1 µg/ml leupeptin,
pepstatin, and E64, and 1 mM PMSF) containing 450
mM NaCL and 1% NP40. The crude lysate was diluted 1:3
with Buffer A. After centrifugation (15 min at 20,000 ×  g
at 4°C) the soluble material was loaded onto a BioRad
Macroprep High Q column (2.5 cm ×  20 cm) equilibrated
with Buffer A + 150 mM NaCl. The column was washed
with 5 column volumes of Buffer A + 150 mM NaCl and 5
column volumes of Buffer A + 250 mM NaCl (no EDTA).
GFP-BLM was eluted with Buffer B (Buffer A + 500 mM
NaCl and no EDTA). Pooled Macroprep Q fractions con-BMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
taining GFP-BLM were loaded onto a 5 ml HiTrap metal
chelate column (Amersham Pharmacia) charged with
NiS04 equilibrated in Buffer B. The metal chelate resin
was washed with successive 10 column volumes of Buffer
B + 10mm imidazole, Buffer B + 50 mM imidazole, and
Buffer B + l00 mM imidazole. Highly purified GFP-BLM
eluted in Buffer B + 200 mM imidazole and was stored at
-70°C. Assays for DNA-dependent ATPase and oligonu-
cleotide unwinding were performed as before [10].
Construction of inducible cell lines expressing GFP-BLM 
and mutant alleles
The SV40-transformed BS cell line GM0855B (bl-
mAsh[2281∆ 6ins7] / bimAsh [2281∆ 6ins7]) [3] was transfected
with a plasmid expressing the tetracycline or doxycycline
(Tet)-responsive transcriptional transactivator from a
CMV promoter [32]. G418-resistant cell lines were se-
lected in DMEM + 10% fetal bovine serum (Clontech,
Tet-free) + 200 µg/ml Geneticin (Invitrogen). Seventeen
G418-resistant clones were screened for transfection ef-
ficiency and Tet-responsiveness. The efficiency was
measured by transient transfection of a CMV promoter-
driven GFP gene (pEGFP-Cl, Clontech) and responsive-
ness by transfection of a Tet-regulated GFP gene (pBi
EGFP, Clontech). One cell line (HG2551a) had an 8%
transfection efficiency (constitutive GFP) and 0.25%
green cells without Tet and 3.8% with 1 µg/ml Tet (15
fold induction and 45% inducible transfection efficiency
vs. constitutive), and was chosen for transfection of GFP-
BLM alleles.
The BLM alleles used here were cloned as fusions with
the C-terminus of EGFP (Clontech). The K695T mis-
sense allele was described before [10]. The deletion alle-
les of BLM were constructed using digestion with two
restriction enzymes and insertion of an oligonucleotide
adapter. The sites and the sequences of the adapters
were:
 ∆ N1 (EcoRI-SmaI, 5'AATCTGCAGCTATGAAATCCC3'/
5'GACGTCGATACTTTAGGG3'),
∆ N2 (SmaI-ClaI, 5'GGGATACTGCTATTTGCAT3'/5'CC
CTATGACGATAAACGTAGC3'),
∆ N3 (ClaI-AvrII, 5'CGATGATCTGACTACCACCC3'/5'T
ACTAGACTGATGGGTGGGATC3'),
 ∆ N4 (XmnI-AhdI, 5'GCTTTCCTCAGCCAAGACAGA3'/
5'CGAAAGGAGTCGGTTCTGTC3'),
∆ H1 (NcoI-SalI, 5'CATGAATCTGGCTG3'/5'TT  AGA
CCGACAGCT3'),
∆ C1 (SalI-PvuI, 5'TCGACATTGACCAGGCGAT3'/5'G
TAACTGGTCCGC3') and ∆ C2 (PvuI-EcoNI,
5'CGCTAATGAAAGGAAGAGGAAAAAGATGCCAG CCT
CC 3'/5'TAGCGATTACTTTCCTTCTCCTTTTTCTACG
GT3').
 The ∆ C2 construction restores the nuclear localization
signal [30]. Oligonucleotides were made by Invitrogen.
The deletion junctions were confirmed by DNA sequenc-
ing.
Cell line HG2551a was transfected [10] with normal and
mutant GFP-BLM genes cloned behind the Tet-respon-
sive promoter in plasmid pTRE (Clontech). Stable trans-
fected cell lines containing these constructions were
selected by two methods: co-transfection of these plas-
mids with a second plasmid containing a hygromycin-re-
sistance gene driven by a Herpes simplex thymidine
kinase promoter or transfection of GFP-BLM allele plas-
mids that had been modified to contain the hygromycin-
resistance gene expression unit. Few useful cell lines
were obtained from the first method. Most transfected
clones that were resistant to 200 µg/ml G418 and 200
µg/ml hygromycin did not produce GFP upon induction.
In contrast transfection with the modified vector where
the two expression units are on the same plasmid pro-
duced many useful cell lines. The ∆ C2 cell line was from
the first transfection method and all of the others were
selected using the second.
Immunoflourescent and western analysis of cell lines
Cells were plated onto glass coverslips in 6 well tissue
culture plates in selective medium, induced the next day
with 1 µg/ml Tet and fixed with 2% paraformaldehyde 24
hours later. Immunofluorescent staining and microsco-
py was as performed previously [20]. Antibody against
human Topoisomerase IIIα  was provided by F. B. John-
son and L. Guarente [33]. Antibody against BLM was de-
scribed before [10]. Antibody against GFP was from
Roche Molecular Biochemicals. Western transfers were
as before [10]. ECF and ECL reagents were purchased
from Amersham/Pharmacia and used according to the
supplier's instructions. SDS 4-12% polyacrylamide gels
and Precision protein molecular weight markers were
from BioRad.
Sister Chromatid Exchange Assay
Fibroblast cell cultures were divided into two T-25 tissue
culture flasks and one was induced with 1 µg/ml Tet the
next day. After a 24 hour period of induction 20 µM
BrdU was added to both flasks. Labeling, colcemid treat-
ment and harvest were as before [10]. Fixed preparations
were dropped onto clean glass slides and stained with 0.1
mg/ml acridine orange for 5 minutes, followed by a wash
in running water for 2 minutes and a 1 minute incubationBMC Cell Biology (2001) 2:11 http://www.biomedcentral.com/1471-2121/2/11
in Sorensen's buffer (67 mM KH2PO4 + 67 mM
Na2HPO4). The wet slides were covered with glass cover-
slips and metaphases photographed immediately with a
Zeiss Axioskop fluorescence microscope using the FITC
filter and a 100×  objective. Images were captured with a
CCD camera (Kodak Micromax 1400) connected to an
Apple Power Mac 9600.
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